SpliceArray
Navigation Links
SpliceArray in Biological News
Products containing specific probes for detecting alternative splice forms protected
...ation described in the patent is the basis for the microarrays in ExonHit's splicearray product line launched earlier this year. The genome profiling market is rap...ally available microarrays designed to detect alternative splicing. Current splicearray products include GPCR, Ion Channel, and Nuclear Receptor family SpliceArray...SpliceArray in Biological Products
Ion Channel SpliceArray Service from ExonHit Therapeutics Inc.
Description: The binding specificity and signaling of the members of the GPCR family are known to be modified by alternative splicing--which has important implications for drug research. With GPCR SpliceArrays you can perform a classical expression profiling and at the same time detect the different alternative...Company:ExonHit Therapeutics Inc.
GPCR SpliceArray Service from ExonHit Therapeutics Inc.
Description: The binding specificity and signaling of the members of the GPCR family are known to be modified by alternative splicing--which has important implications for drug research. With GPCR SpliceArrays you can perform a classical expression profiling and at the same time detect the different alternative...Company:ExonHit Therapeutics Inc.
Custom Splice Arrays from ExonHit Therapeutics Inc.
Description:... Through its splicearray service, ExonHit can design custom microarrays to detect alternative splici... cDNAs aligned to the human genome. Each splice event contained in a custom splicearray is profiled with a patent protected combination of six exon and junction pr...Company:ExonHit Therapeutics Inc.
Apoptosis Pathway SpliceArrays from ExonHit Therapeutics Inc.
Description:...hat are expressed in the samples under study. The Apoptosis and Cell Death splicearray monitors 5806 known and potential splice events derived from 609 genes. Sp...ular species resulting from each splice event. The Apoptosis and Cell Death splicearray service is provided exclusively by ExonHit, a leader in the field of altern...Company:ExonHit Therapeutics Inc.
Other TagsAmendJhaMIFRMITRMITRMITOther Contentsproductproductproductproductproductproductproductproductproductsilencingsilencingsilencingsilencingsilencingsilencingtargetingtargetingtargetingtargetingtargetingtargetingtargetingdiversitydiversitydiversitydiversitydiversitydiversityengineeringengineeringengineeringengineeringengineeringengineeringengineeringfingerprintfingerprintfingerprintfingerprintinteractionsinteractionsinteractionsinteractionsinteractionsinteractionsinteractionsinteractionsinteractions
(Date:11/26/2009)...estering drug tetrathiomolybdate (TM) has been sho...Wilson disease, a disease caused by an overload of... is known. Very little, however, is known about ho... study led by Northwestern University researchers ...ensional structure of TM bound to copper-loaded me...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a le...ina, today announced the expansion of its services...ist, Dr. Doug Macmillan. , ...l is pleased to announce that Dr. Doug Macmillan, ...eted an additional advanced training seminar. RTD...
(Date:11/25/2009)...E,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharm...ecompanywillhosttwoinvestoreventsinDecember: ,,.../10:00a.m.ET ,, Principalinvestigatorswilldis...sedand/orrefractorymultiplemyeloma,asfeaturedatthe...ndExpositioninNewOrleans,LA.Theteleconferencewillb...
(Date:11/25/2009)...S,Nov.25/PRNewswire-USNewswire/--TheBlackAIDSInsti...eexecutiveleadershipfor2010. ,, ThenewBoardMemb...npublicpolicy,law,finance,governmenthealthprograms...ocomesfromawiderangeofpersonalbackgroundsincluding...ithHIVthemselves,andrepresentingmultipleagegroups....
(Date:11/25/2009)...discovery that grew out of a collaboration between...ffer hope to the nearly 10 million Americans who s...so known as hardening of the arteries, peripheral ...problem in which narrowed arteries reduce blood fl... flag for vascular disease, heart attack and strok...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4[1] Research sheds light on workings of anti-cancer drug[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental [0] Onyx Pharmaceuticals Announces December 2009 Investor Events[0] Black AIDS Institute Announces 2010 Board Election Results[1] Engineers, doctors at UCLA develop novel material that could help fight arterial disease
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
(Date:11/23/2009)...t research suggests that a common oral bacterium m...ort by Nichols et al, "Unique Lipids from a Common...ands Capable of Enhancing Autoimmunity," appears i... of Pathology . , Multiple sclerosis (MS), a dis... spinal cord, affects nearly 1 in 700 people in th...
(Date:11/23/2009)... producing some of the highest resolution images o...ts have a deeper understanding how biomolecules ma...ad to a new treatment for kidney stones using biom...ov. 23 online edition of the journal Proceedings ... peptides interact with mineral surfaces by accele...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Existing Drug May Lead to ALS Treatment 59797 1Existing Drug May Lead to ALS Treatment 59797 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |